Controlled trial of combinations of hydroxocobalamin cystine and riboflavine cystine, in Nigerian ataxic neuropathy

16Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Chronic cyanide intoxication of dietary origin and riboflavine deficiency are believed to be major etiological factors in Nigerian tropical ataxic neuropathy. The results are presented of a double blind controlled therapeutic trial of combinations of large doses of hydroxocobalamin and cystine as cyanide binding agents, together with riboflavine or placebos, in Nigerian patients suffering from the tropical ataxic neuropathy. No clinical benefit was demonstrable with any of the treatments.

Cite

CITATION STYLE

APA

Osuntokun, B. O., Langman, M. J. S., Wilson, J., Adeuja, A. O., & Aladetoyinbo. (1974). Controlled trial of combinations of hydroxocobalamin cystine and riboflavine cystine, in Nigerian ataxic neuropathy. Journal of Neurology Neurosurgery and Psychiatry, 37(1), 102–104. https://doi.org/10.1136/jnnp.37.1.102

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free